Enzymatica got the largest order from STADA

| By | Pharmaceutical Distribution, Stada

Enzymatica, a Swedish life science company, has received its largest order to date for a total of about SEK 12 million. The global pharmaceutical company STADA Arzneimittel AG, headquartered in Germany, has ordered Enzymatica’s cold product ColdZyme® Mouth spray for the German, Belgian and Austrian markets for the common cold season after the summer.

The order is a result of the cooperation agreement that Enzymatica and STADA reached in February 2017. The agreement grants STADA exclusive rights to sell, market and distribute ColdZyme in Germany, the largest market for OTC products in Europe, as well as in Belgium and Austria.

“We are now beginning to see the results of our efforts to sign agreements with international distributors for the major OTC markets. The order is the largest in Enzymatica’s history and is worth much more than the entire sales of SEK 9.6 million for the first quarter this year. The order confirms the commercial potential of ColdZyme and our technology platform,” says Fredrik Lindberg, CEO of Enzymatica.

Enzymatica expects to deliver the order at the end of the summer and the revenue will have an impact on the company’s third quarter sales.

SOURCE: globenewswire
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.